欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (2): 167-173.doi: 10.12092/j.issn.1009-2501.2021.02.007

• 基础研究 • 上一篇    下一篇

白藜芦醇抑制大肠埃希菌O104∶H4诱导的结肠上皮细胞NLRP3炎症小体活化

邓莉,田静   

  1. 恩施土家族苗族自治州中心医院脾胃科,恩施 445000,湖北
  • 收稿日期:2020-03-16 修回日期:2021-01-01 出版日期:2021-02-26 发布日期:2021-03-04
  • 通讯作者: 田静,女,硕士,主治医师,研究方向:消化道系统疾病的防治。 E-mail: 120213855@qq.com
  • 作者简介:邓莉,女,本科,主治医师,研究方向:消化道疾病防治。 Tel: 15671881358 E-mail: 1012602374@qq.com
  • 基金资助:
    湖北省卫生健康委员会(ZY2019Q021)

Resveratrol suppresses NLRP3 inflammasome activation in colonic epithelial cells triggered by Escherichia coli O104∶H4

DENG Li, TIAN Jing   

  1. Department of Splenogastroenterology, the Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, Hubei, China
  • Received:2020-03-16 Revised:2021-01-01 Online:2021-02-26 Published:2021-03-04

摘要: 目的:研究白藜芦醇(RES)对大肠埃希菌O104∶H4感染的结肠上皮Caco-2细胞线粒体和氧化应激损伤及NLRP3炎症小体活化的影响。方法:RES(200 μmol/L)预处理Caco-2细胞12 h,然后107 CFU/mL的大肠埃希菌O104∶H4(MOI 10∶1)感染细胞4 h。CCK-8法检测细胞活力,qRT-PCR法分析过氧化物酶体增殖物激活受体γ共激活因子1α(PGC1α)、细胞色素氧化酶4(COX-4)、核呼吸因子1(NRF1)、线粒体转录因子1(TFAM)、超氧化物歧化酶1(SOD1)和血红素加氧酶1(HO-1)mRNA表达水平,Western blot检测炎症小体NLRP3、半胱氨酸天冬氨酸蛋白水解酶-1活化亚基p20(CASP1 p20)、半胱氨酸天冬氨酸蛋白水解酶-1活化亚基p10(CASP1 p10)、pro-IL-1β和IL-1β蛋白表达水平,并对Caco-2细胞线粒体膜电位、氧耗量和活性氧(ROS)水平进行检测。结果:大肠埃希菌O104∶H4感染可明显诱导NLRP3、CASP1 p20、CASP1 p10、IL-1β蛋白和PGC1α、COX-4和NRF1 mRNA表达,促使氧消耗量和ROS水平增高,而细胞活力、TFAM mRNA表达和线粒体膜电位降低(P<0.05);RES处理后能明显抑制NLRP3、CASP1 p20、CASP1 p10、IL-1β蛋白和PGC1α、COX-4和NRF1 mRNA表达,降低氧消耗量和ROS水平,而细胞活力、TFAM mRNA表达和线粒体膜电位增高(P<0.05);另外,ROS抑制剂N-乙酰半胱氨酸(NAC)也能显著抑制NLRP3炎症小体和IL-1β表达水平。 结论:大肠埃希菌O104∶H4感染诱导Caco-2细胞线粒体释放ROS和NLRP3炎症小体活化,而RES可部分改善Caco-2细胞损伤,降低NLRP3炎症小体和ROS水平。

关键词: 白藜芦醇, 大肠埃希菌O104∶H4, 结肠上皮细胞, NLRP3炎症小体

Abstract: AIM: To study the effects of resveratrol (RES) on the mitochondrial damage, oxidative stress injury and NLRP3 inflammasome activation in colonic epithelial cells (Caco-2) induced by Escherichia coli O104∶H4.  METHODS: Caco-2 cells pre-treated with 200 μmol/L RES for 12 h, then cells were infected with 107 CFU/mL Escherichia coli O104∶H4 (MOI 10∶1) for 4 h. CCK-8 was used to detect the cell viability. qRT-PCR was performed to measure the expression levels of PGC1α, COX-4, NRF1, TFAM, SOD1 and HO-1 mRNA. Western blot was used to determine the expressions of NLRP3, CASP1 p20, CASP1 p10, pro-IL-1β and IL-1β. In addition, the mitochondrial membrane potential, oxygen consumption and ROS level were detected. RESULTS: Escherichia coli O104∶H4 infection could induce the expression levels of NLRP3, CASP1 p20, CASP1 p10, IL-1β protein and PGC1α, COX-4, NRF1 mRNA, and promote the oxygen consumption and ROS level, whereas significantly inhibit the cell viability, TFAM mRNA expression and the mitochondrial membrane potential (P<0.05). Furthermore, the expression levels of NLRP3, CASP1 p20, CASP1 p10, IL-1β protein and PGC1α, COX-4, NRF1 mRNA, and the oxygen consumption and ROS level were greatly decreased after treatment with RES in Caco-2 cells infected with Escherichia coli O104∶H4, whereas significantly induce the cell viability, TFAM mRNA expression and the mitochondrial membrane potential (P<0.05). In addition, ROS inhibitor (NAC) also could suppress the expressions of NLRP3 inflammasome and IL-1β. CONCLUSION: Escherichia coli O104∶H4 infection induces mitochondrial ROS release and NLRP3 inflammasome activation in Caco-2 cells, while RES exerts a preventive role in cells upon Escherichia coli O104∶H4 infection partially due to prevention of ROS production and activation of NLRP3 inflammasome.

Key words: resveratrol, Escherichia coli O104∶H4, colonic epithelial cells, NLRP3 inflammasome

中图分类号: